Testing Implementation Strategies to Improve Delivery of PrEP for Pregnant and Postpartum Women in Kenya
NCT ID: NCT05482360
Last Updated: 2025-02-26
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5173 participants
INTERVENTIONAL
2022-01-01
2023-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PrEP Implementation for Mothers in Antenatal Care
NCT03070600
PrEPARE: PrEP in Pregnancy, Accelerating Reach and Efficiency
NCT04712994
STI Testing to Enhance PrEP Use in Pregnancy
NCT06919614
Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum
NCT03386578
Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1
NCT06435026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Package 1
Package 1: Three implementation strategies including fast tracking, provider re-training, and dispensing PrEP in MCH
PrEP Optimization Interventions
There were three bundles of strategies tested determined based on the qualitative information gathered in Aim 1 by stakeholders
Comparator for Package 1
4 facilities were assigned to the comparator group and never received any implementation strategy.
No interventions assigned to this group
Package 2
Package 2: Three implementation strategies including task shifting PrEP counseling from clinicians/nurses to HIV testing services providers (HTS), training different cadres, and dispensing PrEP in MCH
PrEP Optimization Interventions
There were three bundles of strategies tested determined based on the qualitative information gathered in Aim 1 by stakeholders
Package 3
Package 3: Three implementation strategies including use of PrEP educational materials, PrEP health talks in waiting bays and dispensing PrEP in MCH
PrEP Optimization Interventions
There were three bundles of strategies tested determined based on the qualitative information gathered in Aim 1 by stakeholders
Comparison for Package 2
4 facilities were assigned to the comparator group and never received any implementation strategy.
No interventions assigned to this group
Comparison for Package 3
4 facilities were assigned to the comparator group and never received any implementation strategy.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PrEP Optimization Interventions
There were three bundles of strategies tested determined based on the qualitative information gathered in Aim 1 by stakeholders
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
15 Years
100 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anjuli Wagner
Assistant Professor, Global Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anjuli Wagner, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ober Health Center
Homa Bay, , Kenya
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00008392-A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.